Filing Details
- Accession Number:
- 0001161697-21-000406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-24 17:01:05
- Reporting Period:
- 2021-08-20
- Accepted Time:
- 2021-08-24 17:01:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 929985 | J Patrick Mcenany | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2021-08-20 | 80,000 | $3.12 | 4,928,304 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2021-08-20 | 54,161 | $5.52 | 4,874,143 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2021-08-23 | 120,000 | $3.12 | 4,994,143 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2021-08-23 | 82,617 | $5.63 | 4,911,526 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2021-08-20 | 80,000 | $0.00 | 80,000 | $3.12 |
| Common Stock | Options to purchase common stock | Disposition | 2021-08-23 | 120,000 | $0.00 | 120,000 | $3.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,371,667 | 2021-08-28 | No | 4 | M | Direct | |
| 3,251,667 | 2021-08-28 | No | 4 | M | Direct |
Footnotes
- Shares were sold to cover exercise price of options and tax withholding requirements.
- Shares were sold in various lots from $5.455 to $5.601 per share. The listed sale price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $5.59 to $5.675 per share. The listed sale price represents a weighted average price for the shares sold.
- Options vested in three annual tranches beginning on August 28, 2015.
Billionaire Hedge Funds
